Literature DB >> 7876898

Electrostatic complementarity between proteins and ligands. 1. Charge disposition, dielectric and interface effects.

P L Chau1, P M Dean.   

Abstract

Electrostatic interactions have always been considered an important factor governing ligand-receptor interactions. Previous work in this field has established the existence of electrostatic complementarity between the ligand and its receptor site. However, this property has not been treated rigorously, and the description remains largely qualitative. In this work, 34 data sets of high quality were chosen from the Brookhaven Protein Databank. The electrostatic complementary has been calculated between the surface potentials; complementarity is absent between adjacent or neighbouring atoms of the ligand and the receptor. There is little difference between complementarities on the total ligand surface and the interfacial region. Altering the homogeneous dielectric to distance-dependent dielectrics reduces the complementarity slightly, but does not affect the pattern of complementarity.

Mesh:

Substances:

Year:  1994        PMID: 7876898     DOI: 10.1007/bf00123663

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  29 in total

1.  The refined structure of the complex between adenylate kinase from beef heart mitochondrial matrix and its substrate AMP at 1.85 A resolution.

Authors:  K Diederichs; G E Schulz
Journal:  J Mol Biol       Date:  1991-02-05       Impact factor: 5.469

2.  Electrostatic complementarity between proteins and ligands. 2. Ligand moieties.

Authors:  P L Chau; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

3.  Fitting straight lines when both variables are subject to error.

Authors:  D S Riggs; J A Guarnieri; S Addelman
Journal:  Life Sci       Date:  1978 Apr 3-17       Impact factor: 5.037

4.  Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.

Authors:  J F Davies; T J Delcamp; N J Prendergast; V A Ashford; J H Freisheim; J Kraut
Journal:  Biochemistry       Date:  1990-10-09       Impact factor: 3.162

5.  Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.

Authors:  G B Dreyer; D M Lambert; T D Meek; T J Carr; T A Tomaszek; A V Fernandez; H Bartus; E Cacciavillani; A M Hassell; M Minnich
Journal:  Biochemistry       Date:  1992-07-28       Impact factor: 3.162

6.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.

Authors:  P M Fitzgerald; B M McKeever; J F VanMiddlesworth; J P Springer; J C Heimbach; C T Leu; W K Herber; R A Dixon; P L Darke
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

7.  Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis.

Authors:  S S Abdel-Meguid; B Zhao; K H Murthy; E Winborne; J K Choi; R L DesJarlais; M D Minnich; J S Culp; C Debouck; T A Tomaszek
Journal:  Biochemistry       Date:  1993-08-10       Impact factor: 3.162

8.  Structure of holo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus at 1.8 A resolution.

Authors:  T Skarzyński; P C Moody; A J Wonacott
Journal:  J Mol Biol       Date:  1987-01-05       Impact factor: 5.469

9.  Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 A resolution.

Authors:  R Huber; M Schneider; I Mayr; R Müller; R Deutzmann; F Suter; H Zuber; H Falk; H Kayser
Journal:  J Mol Biol       Date:  1987-12-05       Impact factor: 5.469

10.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

Authors:  M Miller; J Schneider; B K Sathyanarayana; M V Toth; G R Marshall; L Clawson; L Selk; S B Kent; A Wlodawer
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

View more
  8 in total

1.  A branch-and-bound method for optimal atom-type assignment in de novo ligand design.

Authors:  N P Todorov; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

2.  The atom assignment problem in automated de novo drug design. 1. Transferability of molecular fragment properties.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

3.  Multiconformational composite molecular potential fields in the analysis of drug action. I. Methodology and first evaluation using 5-HT and histamine action as examples.

Authors:  J G Vinter; K I Trollope
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

4.  Electrostatic complementarity between proteins and ligands. 2. Ligand moieties.

Authors:  P L Chau; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

5.  Electrostatic complementarity between proteins and ligands. 3. Structural basis.

Authors:  P L Chau; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

6.  An automated method for predicting the positions of hydrogen-bonding atoms in binding sites.

Authors:  J E Mills; T D Perkins; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1997-05       Impact factor: 3.686

7.  RosettaSurf-A surface-centric computational design approach.

Authors:  Andreas Scheck; Stéphane Rosset; Michaël Defferrard; Andreas Loukas; Jaume Bonet; Pierre Vandergheynst; Bruno E Correia
Journal:  PLoS Comput Biol       Date:  2022-03-16       Impact factor: 4.779

8.  Electrostatic similarities between protein and small molecule ligands facilitate the design of protein-protein interaction inhibitors.

Authors:  Arnout Voet; Francois Berenger; Kam Y J Zhang
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.